Risk factors associated with thrombosis in patients with antiphospholipid antibodies

Journal of Rheumatology

Volumn 28, Issue 9, 2001, Pages 2018-2024

  Hansen, K E ^a   Kong, D F ^a   Moore, K D ^a   Ortel, T L ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

3 prothrombin; Antiphospholipid antibodies; Diabetes mellitus; Factor v leiden; Hyperlipidemia; Hypertension

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 5; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; ARTIFICIAL NEURAL NETWORK; DNA POLYMORPHISM; FEMALE; HEART SURGERY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS; STATISTICAL MODEL; TOBACCO; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYSIS OF VARIANCE; ANTIBODIES, ANTIPHOSPHOLIPID; ARTERIAL OCCLUSIVE DISEASES; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; ODDS RATIO; PROBABILITY; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SAMPLING STUDIES; SEX DISTRIBUTION; VENOUS THROMBOSIS;

EID: 0034875220     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
2. Familial antiphospholipid antibody syndrome: Criteria for disease and evidence for autosomal dominant inheritance
3. Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies - Prevalence and clinical significance
4. Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies
5. Lack of association between thrombosis in primary antiphospholipid syndrome and the recently described thrombophilic 3′ - Untranslated prothrombin gene polymorphism
6. Hereditary resistance to activated protein C: An uncommon risk factor for thromboembolic disease in lupus patients with antiphospholipid antibodies
7. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome
8. Thrombosis and systemic lupus erythematosus: The Hopkins lupus cohort prospective study
9. Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): Standardization and quantitation of results
10. Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome
11. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
12. 1996 Diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: A 'mission impossible'?
13. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
14. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
15. Neural network analysis to predict treatment outcome
16. Artificial neural networks: Current status in cardiovascular medicine
17. Application of artificial neural networks to clinical medicine
18. Evaluating the yield of medical tests
19. The meaning and use of the area under a receiver operating characteristic (ROC) curve
20. Arterial thrombotic events (TE) in SLE: The Baltimore lupus cohort study
21. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus
22. 506)
23. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
24. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
25. The risk of recurrent deep vein thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
26. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular disease in young adults
27. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women
28. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
29. Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds
30. Mechanism on disorders of coagulation and fibrinolysis in diabetes
31. The hypercoagulable states
32. Hyperlipidemia and coronary disease: Correction of the increased thrombogenic potential with cholesterol reduction
33. Chronic smoking in an animal model: Effects on clotting and fibrinolysis
34. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin
35. Antiphospholipid antibodies developing in the setting of vascular surgery frequently result from exposure to bovine thrombin
36. Pathogenesis and treatment of the antiphospholipid antibody syndrome